Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001546007-20-000017
Filing Date
2020-08-06
Accepted
2020-08-06 11:13:38
Documents
2

Document Format Files

Seq Description Document Type Size
1 Schedule13G.txt SC 13G 7100
2 Exhibit7.txt EX-7 569
  Complete submission text file 0001546007-20-000017.txt   9253
Mailing Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080 650-871-0761
CATALYST BIOSCIENCES, INC. (Subject) CIK: 0001124105 (see all company filings)

EIN.: 562020050 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-82442 | Film No.: 201080517
SIC: 2834 Pharmaceutical Preparations

Mailing Address AEROGOLF CENTER 1B HEIENHAFF SENNINGERBERG N4 1736
Business Address AEROGOLF CENTER 1B HEIENHAFF SENNINGERBERG N4 1736 0035227049100
Assenagon Asset Management S.A. (Filed by) CIK: 0001546007 (see all company filings)

EIN.: 000000000 | State of Incorp.: N4 | Fiscal Year End: 1231
Type: SC 13G